Literature DB >> 22322396

Pharmacokinetic herb-drug interactions (part 1): origins, mechanisms, and the impact of botanical dietary supplements.

Bill J Gurley1.   

Abstract

Phytochemicals have been components of man's diet for millennia and are believed to have played a significant role in steering the functional development of xenobiotic metabolizing enzymes and transporters within the human gastrointestinal tract. Only recently, however, have plant secondary metabolites been recognized as modulators of human drug disposition. Despite exposure to thousands of structurally diverse dietary phytochemicals, only a few appear to significantly modulate human drug metabolizing enzymes and transporters. In some instances, these interactions may have beneficial effects like cancer prevention, whereas others may dramatically affect the pharmacokinetics of concomitantly administered drugs. In today's global economy, the opportunity for exposure to more exotic phytochemicals is significantly enhanced. Formulated as concentrated phytochemical extracts, botanical dietary supplements are vehicles for a host of plant secondary metabolites rarely encountered in the normal diet. When taken with conventional medications, botanical dietary supplements may give rise to clinically significant herb-drug interactions. These interactions stem from phytochemical-mediated induction and/or inhibition of human drug metabolizing enzymes and transporters. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322396     DOI: 10.1055/s-0031-1298273

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  22 in total

1.  Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents.

Authors:  Guannan Li; Charlotte Simmler; Luying Chen; Dejan Nikolic; Shao-Nong Chen; Guido F Pauli; Richard B van Breemen
Journal:  Eur J Pharm Sci       Date:  2017-07-31       Impact factor: 4.384

2.  Chemoenzymatic Synthesis, Characterization, and Scale-Up of Milk Thistle Flavonolignan Glucuronides.

Authors:  Brandon T Gufford; Tyler N Graf; Noemi D Paguigan; Nicholas H Oberlies; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2015-08-27       Impact factor: 3.922

3.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

Review 4.  Clinically Relevant Herb-Micronutrient Interactions: When Botanicals, Minerals, and Vitamins Collide.

Authors:  Bill J Gurley; Alyssa Tonsing-Carter; Sheila L Thomas; E Kim Fifer
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

5.  Safety assessment of the dietary supplement OxyELITE™ Pro (New Formula) in inbred and outbred mouse strains.

Authors:  Isabelle R Miousse; Charles M Skinner; Haixia Lin; Laura E Ewing; Stanley D Kosanke; D Keith Williams; Bharathi Avula; Ikhlas A Khan; Mahmoud A ElSohly; Bill J Gurley; Igor Koturbash
Journal:  Food Chem Toxicol       Date:  2017-08-24       Impact factor: 6.023

6.  National Center for Complementary and Integrative Health Perspectives on Clinical Research Involving Natural Products.

Authors:  Wendy J Weber; D Craig Hopp
Journal:  Drug Metab Dispos       Date:  2020-08-05       Impact factor: 3.922

7.  Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juice.

Authors:  Emily J Johnson; Christina S Won; Kathleen Köck; Mary F Paine
Journal:  Biopharm Drug Dispos       Date:  2017-02-14       Impact factor: 1.627

8.  Dietary Supplement Use Was Very High among Older Adults in the United States in 2011-2014.

Authors:  Jaime J Gahche; Regan L Bailey; Nancy Potischman; Johanna T Dwyer
Journal:  J Nutr       Date:  2017-08-30       Impact factor: 4.798

9.  A systematic approach to evaluate herb-drug interaction mechanisms: investigation of milk thistle extracts and eight isolated constituents as CYP3A inhibitors.

Authors:  Scott J Brantley; Tyler N Graf; Nicholas H Oberlies; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-06-25       Impact factor: 3.922

10.  Protective effects of (-)-epigallocatechin-3-gallate against acetaminophen-induced liver injury in rats).

Authors:  Hsien-Tsung Yao; Yu-Chi Yang; Chen-Hui Chang; Hui-Ting Yang; Mei-Chin Yin
Journal:  Biomedicine (Taipei)       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.